Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.67 |
| ▸ | CA2 | P00918 | 3/20 | 0.67 |
| ▸ | ACHE | P22303 | 2/20 | 0.67 |
| ▸ | BCHE | P06276 | 1/20 | 0.67 |
| ▸ | CES2 | O00748 | 1/20 | 0.67 |
| ▸ | CES1 | P23141 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35319 | 0.92 | CA1 (0.71) | CA1CA2ACHEBCHECES2 | |
| SCHEMBL28336799 | 0.89 | CA1 (0.74) | CA1CA2ACHEBCHECES2 | |
| Dimethyl 4-Nitrophenyl Phosphate SCHEMBL901276 | 0.85 | CA1 (0.68) | CA1CA2ACHEBCHECES2 | |
| SCHEMBL1763157 | 0.85 | CA1 (0.63) | CA1CA2ACHEBCHECES2 | |
| SCHEMBL10410659 | 0.85 | CA1 (0.63) | CA1CA2ACHEBCHECES2 | |
| SCHEMBL959287 | 0.85 | CA1 (0.63) | CA1CA2ACHEBCHECES2 | |
| SCHEMBL10411255 | 0.85 | CA1 (0.68) | CA1CA2ACHEBCHECES2 | |
| P-Nitrophenylphosphate SCHEMBL168768 | 0.82 | CA1 (0.69) | CA1CA2ACHEBCHECES2 | |
| Paraoxon SCHEMBL21114409 | 0.80 | CA1 (1.00) | CA1CA2ACHEBCHECES2 | |
| SCHEMBL6259754 | 0.80 | CA1 (0.94) | CA1CA2ACHEBCHECES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9896714-B2 | Method of detecting phytase activity or protease activity | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2018-02-20 | — | — | US | disclosed |
| EP-2516670-B1 | Method | DUPONT NUTRITION BIOSCI APS (DK) | 2016-08-24 | — | — | EP | disclosed |
| EP-2516670-A1 | METHOD | DuPont Nutrition Biosciences ApS (DK) | 2012-10-31 | — | — | EP | disclosed |
| US-20120264153-A1 | METHOD OF DETECTING PHYTASE ACTIVITY OR PROTEASE ACTIVITY | DANISCO A/S (DK) | 2012-10-18 | — | — | US | disclosed |
| WO-2011077342-A1 | METHOD | DANISCO A/S (DK) | 2011-06-30 | — | — | WO | disclosed |
| EP-1546354-B1 | ANALYTE DETECTION | GE HEALTHCARE BIO SCIENCES (US) | 2010-05-05 | — | — | EP | disclosed |
| EP-1421213-B1 | LABELED NUCLEOSIDE POLYPHOSPHATES | GE HEALTHCARE BIO SCIENCES (US) | 2010-02-17 | — | — | EP | disclosed |
| EP-1427852-B1 | SINGLE NUCLEOTIDE AMPLIFICATION AND DETECTION BY POLYMERASE | GE HEALTHCARE BIO SCIENCES (US) | 2010-02-17 | — | — | EP | disclosed |
| US-7560254-B2 | Allele specific primer extension | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2009-07-14 | — | — | US | disclosed |
| EP-1546354-A4 | ANALYTE DETECTION | GE HEALTHCARE BIO SCIENCES (US) | 2007-08-01 | — | — | EP | disclosed |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-04-24 | — | — | US | disclosed |
| WO-2003020984-A2 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES AND METHODS OF USE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | disclosed |
| EP-0852233-A1 | CYCLOSPORIN PHOSPHATE DERIVATIVES AND MEDICINAL COMPOSITION | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1998-07-08 | — | — | EP | disclosed |
| US-5563129-A | Hydroquinone derivatives and intermediates for production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-10-08 | — | — | US | disclosed |
| US-5534639-A | Hydroquinone derivatives and intermediates for production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-07-09 | — | — | US | disclosed |
| US-5436359-A | Hydroquinone derivatives and intermediates for production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| EP-0560568-A2 | Hydroquinone derivatives and intermediates for production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-09-15 | — | — | EP | disclosed |
| US-5189057-A | Preventing and treating thrombosis | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-23 | — | — | US | disclosed |
| EP-0467691-A1 | Saccharoascorbic acid derivatives and their use | Takeda Chemical Industries, Ltd. (JP) | 1992-01-22 | — | — | EP | disclosed |
| US-3974188-A | PHOSPHATE | THE LION DENTIFRICE CO., LTD. (JA) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | RNGTT, DNTT, PNP | CA1 3131/4885CA2 2432/4885ACHE 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.